BMO-T -1.06 LII-N -7.44 CSU-T -58.93 ARE-T -0.14 NTR-T 0.22 ZID-T 0.21 HSUV.U-T 0.09
Afexa Life Sciences Inc. (FXA-T)

Afexa Life Sciences Inc. (FXA-T)

6 watching

0.00
0.00 (0.00%) 1d
0

Related posts

Nervous markets await Nvidia
COMMENT

Afexa Life Sciences Inc.(FXA-T)

Mar 12, 2007
A marketing company. A little bit of controversy. Want to label their product in the US. Never enthralled with marketing companies. Costs a lot of money and you are at the mercy of the vagueness of the consumer.
Peter HodsonPeter Hodson
No
Unlock Rating
$2.490

Stock price when the opinion was issued

biotechnology pharmaceutical
HOLD

Afexa Life Sciences Inc.(FXA-T)

Feb 26, 2007
Manufactures ColdFX. Loves the product, but a little concerned about the share price. Revenues are considerably smaller than the market cap. A little ahead of itself.
Michael DecterMichael Decter
No
Unlock Rating
$2.400

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Afexa Life Sciences Inc.(FXA-T)

Dec 28, 2006
Started launching ColdFX in the US and want to go through the full trial process to get approval as to what they can claim on the product. Expensive stock.
Peter HodsonPeter Hodson
No
Unlock Rating
$2.810

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Afexa Life Sciences Inc.(FXA-T)

Nov 02, 2006
Had a long drop from December to May which was followed by a number of upward steps. Those are very important levels and he thinks the stock probably has more positive news in it. Every time there is a rally, there is a lot of volume with it.
Jeff Parent B. Eng. FCSI CIMJeff Parent B. Eng. FCSI CIM
No
Unlock Rating
$3.980

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Afexa Life Sciences Inc.(FXA-T)

Mar 01, 2005
Great product. Watch for fads. Great marketing company.
Peter HodsonPeter Hodson
No
Unlock Rating
$2.840

Stock price when the opinion was issued

biotechnology pharmaceutical
WATCH

Afexa Life Sciences Inc.(FXA-T)

Feb 24, 2005
A very interesting company. Using ginseng extract to create a remedy for colds. (ColdFX) The product has just taken off. Still looking at it. If they go into the US, it could be a big boost. Might be a little expensive here.
Jean-Francois TardifJean-Francois Tardif
No
Unlock Rating
$2.630

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Afexa Life Sciences Inc.(FXA-T)

Dec 20, 2004
Stock has had a huge run. Huge growth opportunity.Product ColdFX seems to be working very well. Negative is that it is trading at about 31 X sales. Very high risk.
Peter HodsonPeter Hodson
No
Unlock Rating
$2.510

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 7 of 7 entries
  • «
  • ‹
  • 1
  • ›
  • »

Afexa Life Sciences Inc.(FXA-T) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Afexa Life Sciences Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Afexa Life Sciences Inc.(FXA-T) Frequently Asked Questions

What is Afexa Life Sciences Inc. stock symbol?

Afexa Life Sciences Inc. is a OTC stock, trading under the symbol FXA-T on the (). It is usually referred to as or FXA-T

Is Afexa Life Sciences Inc. a buy or a sell?

In the last year, there was no coverage of Afexa Life Sciences Inc. published on Stockchase.

Is Afexa Life Sciences Inc. a good investment or a top pick?

Afexa Life Sciences Inc. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Afexa Life Sciences Inc..

Why is Afexa Life Sciences Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Afexa Life Sciences Inc. worth watching?

0 stock analysts on Stockchase covered Afexa Life Sciences Inc. In the last year. It is a trending stock that is worth watching.

What is Afexa Life Sciences Inc. stock price?

On , Afexa Life Sciences Inc. (FXA-T) stock closed at a price of $.

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

CMG-N -0.15$50.63
MSFT-Q -4.68$450.18
RIO-N 0.46$61.58
SCHW-N 0.09$87.4
AXP-N -1.96$285.22

Today's Top Picks

BMO-T -1.06$142.67
LII-N -7.44$567.16
CSU-T -58.93$4841.07
ARE-T -0.14$18.9
NTR-T 0.22$81.88

Popular Articles

Latest Sell Signals

AAPL-Q -6.09$195.27
BCE-T -0.22$29.53
TMO-N -6.82$393.66
CNR-T -3.08$144.21
DOCS-N -0.24$51.02

Most Recent Experts

Brian Madden

Brian Madden

First Avenue Investment Counsel

Stockchase Insights

Stockchase Insights

5i Research

Jenny Harrington, CEO, Gilman Hill Asset Management

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Jim Lebenthal

Jim Lebenthal

Cerity Partners

Stephanie Link, Chief investment strategist, Hightower

Stephanie Link, Chief investment strategist, Hightower

Hightower

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica